Health

Major Breakthrough: DragonFly-T™ First Transcatheter Tricuspid Valve Repair Surgery in China

HANGZHOU, China, Dec. 21, 2020 /PRNewswire/ -- On December 15, 2020, Professor Wang Jian'an's team from the Second Hospital of Zhejiang University School of Medicine successfully applied the DragonFly-T™ Transcatheter Tricuspid Valve Clamping System to perform the first human clinical application...

2020-12-21 22:18 2154

Longevity Acquisition Corporation Announces 4D pharma Joining Landmark Parkinson's Progression Markers Initiative

NEW YORK, Dec. 21, 2020 /PRNewswire/ -- Longevity Acquisition Corporation (NASDAQ: LOAC) (the "Company"), a publicly-traded special purpose acquisition company, announced today that onDecember 18, 2020, 4D pharma plc (AIM: DDDD) ("4D pharma"), a pharmaceutical company leading the development of L...

2020-12-21 21:00 11289

ImmuneMed's hzVSF-v13, COVID-19 clinical trials accelerate development of the treatment

Followed by Russia, Indonesia, and Korea, the second phase of the COVID-19 clinical trial was approved inItaly on Friday, December 18, 2020. CHUNCHEON, South Korea, Dec. 20, 2020 /PRNewswire/ -- The broad spectrum antiviral therapeutic, 'hzVSF-v13(humanized Virus Suppressing Factor)' being devel...

2020-12-21 10:43 1412

Peijia Medical and HighLife Enter Into License and Technology Transfer Agreement for Transeptal Mitral Valve Replacement in Greater China

SUZHOU, China and PARIS, Dec. 20, 2020 /PRNewswire/ -- Peijia Medical Ltd (HK Stock Code: 09996) and HighLife SAS, aParis-based medical device company, focused on the development of a unique transeptal mitral valve replacement ("TMVR") system to treat patients suffering from mitral regurgitation,...

2020-12-21 10:00 4127

Teijin Pharma and TransThera Biosciences Form Strategic R&D Collaboration

TOKYO and NANJING, China, Dec. 18, 2020 /PRNewswire/ -- Teijin Pharma Limited  ("Teijin Pharma"), the core company of the Teijin Group 's healthcare business headquartered in Tokyo, Japan, and TransThera Biosciences Co. Ltd. ("TransThera"),...

2020-12-18 23:30 3894

Medtecs Chosen as Asian Development Bank's Partner to Supply Vital PPE to Asian Developing Countries Amidst COVID-19 Pandemic

TAIPEI, Dec. 18, 2020 /PRNewswire/ -- Medtecs Group, a leading personal protective equipment (PPE) supplier based inTaiwan, had passed the rigorous procurement process of the Asian Development Bank (ADB) inJune 2020 to become the ADB's supplier of critical protective gear for frontline health wor...

2020-12-18 18:22 2571

Amidst COVID-19 Pandemic, Medtecs Group Transforms Itself into the World's Biggest Stockpiling Solutions Provider

TAIPEI, Dec. 18, 2020 /PRNewswire/ -- Taiwan has been lauded by international communities for its standout performance in containing the outbreak of the coronavirus (COVID-19). In the meantime, Medtecs Group, a company headquartered inTaipei, Taiwan has taken off to become the world's leading sup...

2020-12-18 15:27 1897

Beijing steps up efforts of further opening up

BEIJING, Dec. 17, 2020 /PRNewswire/ -- This is a report from China.org.cn: Beijing received approval from the State Council in September to build a comprehensive demonstration zone for further opening up the service sector and a pilot free trade zone. Since then, it has completed 57 out of its pl...

2020-12-18 12:33 2072

I Peace, Inc. and Avery Therapeutics announce collaboration to bring iPSC derived cell therapy for heart failure to the clinic

I Peace's GMP-grade iPSCs are key to manufacture Avery Therapeutics' MyCardia™, a proprietary tissue-engineered heart graft developed to treat heart failure TUCSON, Ariz. and PALO ALTO, Calif., Dec. 16, 2020 /PRNewswire/ -- Avery Therapeutics, aTucson-based company dedicated to advancing tissue-e...

2020-12-17 08:41 2110
1 ... 309310311312313

Week's Top Stories